Evidence map›Paper›PMID 25071554›Full record

ArticleFrontiers in aging neuroscience2014

Application of a MRI based index to longitudinal atrophy change in Alzheimer disease, mild cognitive impairment and healthy older individuals in the AddNeuroMed cohort.

Carlos Aguilar, J-Sebastian Muehlboeck, Patrizia Mecocci, Bruno Vellas, Magda Tsolaki, Iwona Kloszewska, Hilkka Soininen, Simon Lovestone, Lars-Olof Wahlund, Andrew Simmons and 2 more

Abstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Landmark-Based Alzheimer's Disease Diagnosis Using Longitudinal Structural MR Images.Medical computer vision and Bayesian and graphical models for biomedical imaging : MICCAI 2016 international workshop, MCV and BAMBI, Athens, Greece, October 21, 2016 : revised selected papers · 2016
    Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Carlos AguilarDivision of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet Stockholm, Sweden.
J-Sebastian MuehlboeckDivision of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet Stockholm, Sweden ; Department of Neuroimaging and Department of Old Age Psychiatry, Institute of Psychiatry, King's College London London, UK.
Patrizia MecocciInstitute of Gerontology and Geriatrics, University of Perugia Perugia, Italy.
Bruno VellasINSERM U 558, University of Toulouse Toulouse, France.
Magda TsolakiDepartment of Classics, Aristotle University of Thessaloniki Thessaloniki, Greece.
Iwona KloszewskaDepartment of Old Age Psychiatry and Psychotic Disorders, Medical University of Lodz Lodz, Poland.
Hilkka SoininenDepartment of Neurology, University and University Hospital of Kuopio Finland.
Simon LovestoneDepartment of Neuroimaging and Department of Old Age Psychiatry, Institute of Psychiatry, King's College London London, UK ; NIHR Biomedical Research Centre for Mental Health and NIHR Biomedical Research Unit for Dementia London, UK.
Lars-Olof WahlundDivision of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet Stockholm, Sweden.
Andrew SimmonsDepartment of Neuroimaging and Department of Old Age Psychiatry, Institute of Psychiatry, King's College London London, UK ; NIHR Biomedical Research Centre for Mental Health and NIHR Biomedical Research Unit for Dementia London, UK.
Eric WestmanDivision of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet Stockholm, Sweden.
AddNeuroMed Consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cross sectional studies of patients at risk of developing Alzheimer disease (AD) have identified several brain regions known to be prone to degeneration suitable as biomarkers, including hippocampal, ventricular, and whole brain volume. The aim of this study was to longitudinally evaluate an index based on morphometric measures derived from MRI data that could be used for classification of AD and healthy control subjects, as well as prediction of conversion from mild cognitive impairment (MCI) to AD. Patients originated from the AddNeuroMed project at baseline (119 AD, 119 MCI, 110 controls (CTL)) and 1-year follow-up (62 AD, 73 MCI, 79 CTL). Data consisted of 3D T1-weighted MR images, demographics, MMSE, ADAS-Cog, CERAD and CDR scores, and APOE e4 status. We computed an index using a multivariate classification model (AD vs. CTL), using orthogonal partial least squares to latent structures (OPLS). Sensitivity, specificity and AUC were determined. Performance of the classifier (AD vs. CTL) was high at baseline (10-fold cross-validation, 84% sensitivity, 91% specificity, 0.93 AUC) and at 1-year follow-up (92% sensitivity, 74% specificity, 0.93 AUC). Predictions of conversion from MCI to AD were good at baseline (77% of MCI converters) and at follow-up (91% of MCI converters). MCI carriers of the APOE e4 allele manifested more atrophy and presented a faster cognitive decline when compared to non-carriers. The derived index demonstrated a steady increase in atrophy over time, yielding higher accuracy in prediction at the time of clinical conversion. Neuropsychological tests appeared less sensitive to changes over time. However, taking the average of the two time points yielded better correlation between the index and cognitive scores as opposed to using cross-sectional data only. Thus, multivariate classification seemed to detect patterns of AD changes before conversion from MCI to AD and including longitudinal information is of great importance.

Indexed as

Alzheimer diseaseAPOE4MCIMRImultivariate statisticsOPLS

Identifiers

PMID25071554
PMCPMC4094911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.